natgillin/translations-raw huggingface dataset:
EUR 330000 for Austria;
330000 EUR za Avstrijo;
EUR 4200000 for Poland;
4200000 EUR za Poljsko;
EUR 0 for Romania;
0 EUR za Romunijo;
EUR 425000 for Slovakia;’.
425000 EUR za Slovaško;“.
In Article 14(2), point (c) is replaced by the following:
13 V členu 14(2) se besedilo točke (c) nadomesti z naslednjim:
EUR 3000000 for Poland’.
3000000 EUR za Poljsko“.
In Article 15(2), point (c), is replaced by the following:
V členu 15(2) se točka (c) nadomesti z naslednjim:
EUR 4650000 for Poland’.
4650000 EUR za Poljsko“.
Article 16(5), points (b) to (e) are replaced by the following:
V členu 16(5) se točke od (b) do (e) nadomestijo z naslednjim:
EUR 225000 for Germany;
225000 EUR za Nemčijo;
EUR 860000 for Estonia;
860000 EUR za Estonijo;
EUR 700000 for Latvia;
700000 EUR za Latvijo;
EUR 380000 for Slovenia;’.
380000 EUR za Slovenijo;“.
In Article 18, paragraph 5 is amended as follows:
V členu 18 se odstavek (5) spremeni:
In point (a) ‘EUR 400000’ is replaced by ‘EUR 650000’;
v točki (a) se „400000 EUR“ nadomesti s „650000 EUR“;
In point (c) ‘EUR 300000’ is replaced by ‘EUR 350000’.
v točki (c) se „300000 EUR“ nadomesti s „350000 EUR“.
Done at Brussels, 4 December 2008.
V Bruslju, 4. decembra 2008
of 9 December 2008
z dne 9. decembra 2008
amending Decision 2008/798/EC
o spremembi Odločbe 2008/798/ES
(notified under document number C(2008) 8197)
(notificirano pod dokumentarno številko C(2008) 8197)
Having regard to Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety [1], and in particular Article 53(1), (b) thereof,
ob upoštevanju Uredbe (ES) št. 178/2002 Evropskega parlamenta in Sveta z dne 28. januarja 2002 o določitvi splošnih načel in zahtevah živilske zakonodaje, ustanovitvi Evropske agencije za varnost hrane in postopkih, ki zadevajo varnost hrane [1], in zlasti člena 53(1)(b) Uredbe,
High levels of melamine were found in infant milk and other milk products in China.
V mleku za dojenčke in drugih mlečnih proizvodih na Kitajskem so ugotovili visoko vsebnost melamina.
To counter the risk for health that may result from exposure to the melamine content of feed and food products, Commission Decision 2008/798/EC imposing special conditions governing the import of products containing milk or milk products originating in or consigned from China, and repealing Commission Decision 2008/757/EC, provides for a prohibition to import into the Community products containing milk or milk products, intended for the particular nutritional use of infants and young children, and requires Member States to perform systematic checks at import on other feed and food containing milk or milk products.
Za preprečitev tveganja za zdravje kot posledice izpostavljenosti melaminu v živilih in krmi Odločba Komisije 2008/798/ES o uvedbi posebnih pogojev za uvoz proizvodov, ki vsebujejo mleko ali mlečne proizvode, s poreklom ali poslanih s Kitajske ter o razveljavitvi Odločbe Komisije 2008/757/ES določa, da se v Skupnost prepove uvoz proizvodov, ki vsebujejo mleko ali mlečne proizvode za posebne prehranske namene za dojenčke ali majhne otroke, in zahteva, da države članice opravljajo sistematične preglede pri uvozu drugih živil in krme, ki vsebujejo mleko ali mlečne proizvode.
That Decision also requires Member States to withdraw from the market any such product found to contain melamine in excess of 2,5 mg/kg product.
Navedena odločba zahteva tudi, da države članice umaknejo iz prometa vse takšne proizvode, ki vsebujejo več kot 2,5 mg melamina na kg proizvoda.
According to information made available by the Member States through the Rapid Alert System for Feed and Food, high level of melamine have been found recently also in products containing soya or soya products imported from China.
Po podatkih, ki so jih države članice dale na voljo prek sistema hitrega obveščanja za živila in krmo, so nedavno ugotovili visoko vsebnost melamina tudi v proizvodih, ki vsebujejo sojo ali sojine proizvode in so uvoženi s Kitajske.
Melamine has also been found in ammonium bicarbonate, used in food industry as raising agent.
Melamin je bil ugotovljen tudi v amonijevem bikarbonatu, ki se v živilski industriji uporablja kot sredstvo za vzhajanje.
It is therefore appropriate to extend the measures laid down in Commission Decision 2008/798/EC also to those products.
Zato je primerno, da se ukrepi iz Odločbe Komisije 2008/798/ES razširijo tudi na navedene proizvode.
Decision 2008/798/EC is amended as follows:
Odločba 2008/798/ES se spremeni:
‘Member States shall prohibit the import into the Community of products containing milk, milk products, soya or soya products intended for the particular nutritional use of infants and young children within the meaning of Council Directive 89/398/EEC on foods for particular nutritional uses, originating or consigned from China.
„Države članice prepovejo uvoz v Skupnost proizvodov za posebne prehranske namene za dojenčke ali majhne otroke, ki imajo poreklo s Kitajske ali so od tam poslani in vsebujejo mleko, mlečne proizvode, sojo ali sojine proizvode v smislu Direktive Sveta 89/398/EGS o živilih za posebne prehranske namene.
Member States shall also ensure that any such product found after the entry into force of this Decision on the market shall be immediately withdrawn and destroyed.’
Države članice prav tako zagotovijo, da se vsak takšen proizvod, ki se odkrije na trgu po začetku veljavnosti te odločbe, nemudoma umakne in uniči.“
In Article 2, paragraph 2 is replaced by the following:
V členu 2 se odstavek 2 nadomesti z naslednjim:
‘Member States shall carry out documentary, identity and physical checks, including laboratory analysis, on all consignments originating in or consigned from China of ammonium bicarbonate intended for food and feed and of feed and food containing milk, milk products, soya or soya products.
„Države članice pregledajo dokumentacijo in identiteto ter opravijo fizične preglede, vključno z laboratorijskimi analizami, vseh pošiljk, ki imajo poreklo s Kitajske ali so od tam poslane ter zajemajo amonijev bikarbonat za živila in krmo ter živila in krme, ki vsebujejo mleko, mlečne proizvode, sojo ali sojine proizvode.
Consignments shall be detained pending the availability of the results of the laboratory analysis.’
Pošiljke se zadržijo, dokler niso na voljo rezultati laboratorijske analize.“
‘Feed and food business operators or their representatives shall give prior notification to the point of control referred to in Article 2(3) of the estimated date and time of arrival of all consignments originating in or consigned from China of feed and food containing milk, milk products, soya or soya products.’
„Nosilci živilske dejavnosti in dejavnosti proizvodnje krme ali njihovi predstavniki predhodno obvestijo kontrolno točko iz člena 2(3) o pričakovanem datumu in času prihoda pošiljke, ki imajo poreklo s Kitajske ali so od tam poslane in zajemajo krmo ali živila, ki vsebujejo mleko, mlečne proizvode, sojo ali sojine proizvode.“
Done at Brussels, 9 December 2008.
V Bruslju, 9. decembra 2008
Council Decision 2008/922/CFSP
Sklep Sveta 2008/922/SZVP
Having regard to Council Common Position 2004/161/CFSP [1], and in particular Article 6 thereof, in conjunction with Article 23(2) of the Treaty on European Union,
ob upoštevanju Skupnega stališča Sveta 2004/161/SZVP [1] in zlasti člena 6 Skupnega stališča v povezavi s členom 23(2) Pogodbe o Evropski uniji,
By Common Position 2004/161/CFSP, the Council adopted measures, inter alia, to prevent the entry into or transit through the territories of Member States and to freeze the funds and economic resources of members of the Government of Zimbabwe and of natural or legal persons, entities or bodies associated with them, and of any other natural or legal persons whose activities seriously undermine democracy, respect for human rights and the rule of law in Zimbabwe, a list of whom is set out in the Annex to the said Common Position.
Svet je s Skupnim stališčem 2004/161/SZVP med drugim sprejel ukrepe za preprečitev vstopa na ozemlje držav članic ali tranzita prek njega ter za zamrznitev sredstev in gospodarskih virov, ki pripadajo članom zimbabvejske vlade ter z njimi povezanim fizičnim ali pravnim osebam, subjektom ali organizacijam ter drugim fizičnim ali pravnim osebam, katerih dejanja predstavljajo hudo grožnjo demokraciji ter spoštovanju človekovih pravic in pravne države v Zimbabveju; seznam teh oseb je v prilogi k zadevnemu skupnemu stališču.
Following the violence organised and committed by the Zimbabwean authorities during the presidential election campaign in 2008, the Council decided to add certain other persons and entities to the list set out in the Annex to Common Position 2004/161/CFSP, by the adoption on 22 July 2008 of Decision 2008/605/CFSP [2].
Zaradi nasilja, ki so ga med kampanjo za predsedniške volitve 2008 organizirale in izvajale oblasti v Zimbabveju, je Svet sklenil, da na seznam v prilogi k Skupnemu stališču 2004/161/SZVP uvrsti še nekatere druge osebe in subjekte; v ta namen je 22. julija 2008 sprejel Sklep 2008/605/SZVP [2].
The Council also decided to reinforce the restrictive measures on preventing the entry into or transit through the territories of Member States of the natural persons listed in the Annex to Common Position 2004/161/CFSP, by the adoption on 31 July 2008 of Common Position 2008/632/CFSP [3].
Poleg tega je Svet sklenil poostriti omejevalne ukrepe v zvezi s prepovedjo vstopa na ozemlje držav članic ali prehoda prek njega fizičnim osebam s seznama v Prilogi k Skupnemu stališču 2004/161/SZVP; v ta namen je 31. julija 2008 sprejel Skupno stališče 2008/632/SZVP [3].
Given the violence organised and committed by the Zimbabwean authorities and the continuing blocking of the implementation of the political agreement signed on 15 September 2008, certain persons should be added to the list set out in the Annex to Common Position 2004/161/CFSP.
Zaradi organiziranega nasilja, ki ga oblasti v Zimbabveju še vedno izvajajo in zaradi neizvajanja političnega sporazuma, podpisanega 15. septembra 2008, bi bilo treba na seznam v Prilogi k Skupnemu stališču 2004/161/SZVP uvrstiti še nekatere osebe in subjekte.
However, there is no longer any reason to keep one person on the list set out in the Annex to Common Position 2004/161/CFSP.
Vendar pa ni več razlogov, da se na seznamu v Prilogi k Skupnemu stališču 2004/161/SZVP obdrži ena oseba.
The Annex to Common Position 2004/161/CFSP should be revised accordingly,
Prilogo k Skupnemu stališču 2004/161/SZVP bi bilo treba ustrezno spremeniti –
The persons appearing in Annex I to this Decision shall be added to the list in the Annex to Common Position 2004/161/CFSP.
Na seznam v Prilogi k Skupnemu stališču 2004/161/SZVP se dodajo osebe, navedene na seznamu v Prilogi I k temu sklepu.
The person appearing in Annex II to this Decision shall be withdrawn from the list in the Annex to Common Position 2004/161/CFSP.
Iz seznama v Prilogi k Skupnemu stališču 2004/161/SZVP se odstrani oseba, navedena na seznamu v Prilogi II k temu sklepu.
OJ L 194, 23.7.2008, p. 34.
UL L 194, 23.7.2008, str. 34.
OJ L 205, 1.8.2008, p. 53.
UL L 205, 1.8.2008, str. 53.
Persons referred to in Article 1(1)
Osebe iz člena 1(1)
Member of Parliament elect for Mudzi North, directly involved in the campaign of terror waged before and after the elections
poslanec iz okrožja Severni Mudzi, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Major Kairo (alias Cairo) Mhandu
major Kairo (tudi Cairo) Mhandu
ZNA, directly involved in the campaign of terror waged before and after the elections
pripadnik zimbabvejske nacionalne vojske, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Brigadier General Sibusio Bussie Moyo
brigadni general Sibusio Bussie Moyo
Brigadier General Richard Ruwodo
brigadni general Richard Ruwodo
Promoted on 12 August to the rank of Major General (retired); former Acting PUS for Ministry of Defence, directly involved in the campaign of terror waged before and after the elections
avgusta povišan v generalmajorja (upokojen); nekdanji vršilec dolžnosti stalnega državnega podsekretarja na ministrstvu za obrambo, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Superintendent (retired), directly involved in the campaign of terror waged before and after the elections
višji inšpektor (upokojen), neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Assistant Inspector ZRP, directly involved in the campaign of terror waged before and after the elections
pomočnik inšpektorja zimbabvejskih policijskih sil (ZRP), neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Superintendent, directly involved in the campaign of terror waged before and after the elections
višji inšpektor, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Assistant Commissioner, directly involved in the campaign of terror waged before and after the elections
pomočnik komisarja, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
SGT, directly involved in the campaign of terror waged before and after the elections
narednik, neposredno udeležen v organiziranem nasilju pred volitvami in po njih
Provincial Governor for Mashonaland Central
guverner province osrednji Mashonaland
Provincial Governor for Mashonaland West
guverner province zahodni Mashonaland
The person referred to in Article 1(2)
Osebe iz člena 1(2)
ZANU (PF) Politburo Deputy Secretary General for Economic Affairs (former Minister of Finance), born 22.3.1950
namestnik generalnega sekretarja za gospodarske zadeve v politbiroju ZANU (PF) (nekdanji minister za finance), rojen 22.3.1950;
on the application of Article 8 of Directive 98/79/EC of the European Parliament and of the Council
o uporabi člena 8 Direktive 98/79/ES Evropskega parlamenta in Sveta
(notified under document number C(2008) 7378)
(notificirano pod dokumentarno številko C(2008) 7378)
Having regard to Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in-vitro diagnostic medical devices [1], and in particular Article 8 thereof,
ob upoštevanju Direktive 98/79/ES Evropskega parlamenta in Sveta z dne 27. oktobra 1998 o in vitro diagnostičnih medicinskih pripomočkih [1] in zlasti člena 8 Direktive,
The Portuguese medical device authority Infarmed has, by letter of 29 July 2005 [2] addressed to the Italian company Medical Biological Service SRL (hereafter MBS), forbidden the marketing of their HIV in-vitro diagnostic test kit ‘HIV 1 & 2 Ab’ (hereafter the HIV test).
Portugalski organ za medicinske pripomočke INFARMED je s pismom z dne 29. julija 2005 [2] italijanskemu podjetju Medical Biological Service S.R.L. (v nadaljnjem besedilu „MBS“) prepovedal trženje kompleta za in vitro diagnostične teste za odkrivanje HIV „HIV 1&2 Ab“ (v nadaljnjem besedilu „test HIV“).
Infarmed also obliged the Portuguese distributor Prestifarma Lda to recall the product on behalf of MBS.
INFARMED je ravno tako zahteval od portugalskega distributerja Prestifarma Lda., da v imenu MBS odpokliče izdelek.
By letter of 1 September 2005 [3] Infarmed notified these measures under Article 13 of Directive 98/79/EC.
S pismom z dne 1. septembra 2005 [3] je INFARMED priglasil te ukrepe po členu 13 Direktive 98/79/ES.
As justification for their measure Portugal referred to the German Paul-Ehrlich-Institut’s health surveillance report ‘NCAR DE-2005-07-30’ (PEI Case No PEI0026/05).
Portugalska je svoj ukrep utemeljila s poročilom o spremljanju zdravstvenega stanja „NCAR DE-2005-07-30“ (PEI primer št. PEI0026/05), ki ga je izdal nemški inštitut Paul-Ehrlich.
A subsequent exchange of letters clarified that the NCAR reference was misquoted and that the correct NCAR report number was DE-2005-07-07-30 and that this report is identical to the NCAR report DE-2005-07-27-30.
Z naknadno izmenjavo pisem je bilo ugotovljeno, da je referenca NCAR napačno navedena ter da je pravilna številka poročila NCAR DE-2005-07-07-30 in da je to poročilo enako poročilu NCAR DE-2005-07-27-30.
The NCAR report DE-2005-07-07-30 states that, shortly after an HIV infection, the HIV test needs 10 to 18 days more than comparable tests to detect the infection (low early sero-conversion sensitivity).
Poročilo NCAR DE-2005-07-07-30 navaja, da kmalu po okužbi s HIV test HIV potrebuje 10–18 dni več kot primerljivi testi za odkritje okužbe (nizka občutljivost na zgodnjo serokonverzijo).
For the same reason, the Slovak Medical University had, in its test report of 28 October 2004 [4], recommended the Slovak notified body EVPÚ not to certify the HIV test.
Iz istega razloga je slovaška medicinska fakulteta v poročilu o testu z dne 28. oktobra 2004 [4] priporočila slovaškemu priglašenemu organu EVPÚ, da ne potrdi testa HIV.
The test did thus not fulfil the requirement of being conform to the ‘state of the art’ in the meaning of Annex I (Essential requirements) section A.2 of Directive 98/79/EC and section 3.1.8, third sentence, of the Common technical specifications for in-vitro diagnostic medical devices annexed to Commission Decision 2002/364/EC of 7 May 2002 on common technical specifications for in-vitro diagnostic medical devices [5].
Zato test ni izpolnil zahteve glede skladnosti z „najnovejšim tehničnim razvojem“ v smislu oddelka A.2 Priloge I (Bistvene zahteve) k Direktivi 98/79/ES in tretjim stavkom oddelka 3.1.8 skupnih tehničnih specifikacij za in vitro diagnostične pripomočke, priloženih Odločbi Komisije 2002/364/ES z dne 7. maja 2002 o skupnih tehničnih specifikacijah za in vitro diagnostične medicinske pripomočke [5].
Moreover, as stated by the Paul-Ehrlich-Institut in its letter to the German Ministry of Health of 12 December 2005 [6], the documentation made available by the manufacturer shows that the HIV test did not detect all true positive samples, as required by 3.1.8, first sentence, of the Common technical specifications.
Poleg tega je po navedbah Inštituta Paul-Ehrlich v pismu nemškemu ministrstvu za zdravje z dne 12. decembra 2005 [6] iz dokumentacije, ki jo je predložil proizvajalec, razvidno, da se s testom HIV ne odkrijejo vsi resnično pozitivni vzorci, kakor zahteva prvi stavek oddelka 3.1.8 skupnih tehničnih specifikacij.
This failure has never been explained by the manufacturer or his notified body as required by paragraph 3.1.5 of the Common technical specifications.
Te napake ni proizvajalec ali njegov priglašeni organ nikoli pojasnil, kakor zahteva odstavek 3.1.5 skupnih tehničnih specifikacij.
Thus the HIV test does not fulfil sections 3.1.8, first sentence, and 3.1.5 of the Common technical specifications.
Test HIV torej ne izpolnjuje prvega stavka oddelka 3.1.8 in oddelka 3.1.5 skupnih tehničnih specifikacij.
MBS modified the HIV test after taking note of the NCAR report DE-2005-07-07-30.
MBS je spremenil test HIV po seznanitvi s poročilom NCAR DE-2005-07-07-30.
However, the modification did not improve the early sero-conversion sensitivity of the HIV test, as stated by the Paul-Ehrlich-Institut later in a report of 23 August 2007 [7].
Vendar sprememba ni izboljšala občutljivosti testa HIV na zgodnjo serokonverzijo, kakor je Inštitut Paul-Ehrlich pozneje navedel v poročilu z dne 23. avgusta 2007 [7].
As stated on page 10 of this report, the modified test also fails to detect samples already confirmed as true positive by Western blot or immunoblot assays.
Kakor je navedeno na strani 10 tega poročila, s spremenjenim testom ravno tako ni mogoče odkriti vzorcev, ki so že potrjeni kot resnično pozitivni s testom Western blot ali imunoblot.
The Commission consulted the Member States by letter of 22 March 2007 (D(2007) 7800), the involved notified bodies and institutes by letter of 21 March 2007 (D(2007) 7817), and MBS by letter of 11 June 2007 (D(2007) 16597).
Komisija se je posvetovala z državami članicami s pismom z dne 22. marca 2007 (D(2007)7800), z vpletenimi priglašenimi organi in inštituti s pismom z dne 21. marca 2007 (D(2007)7817) ter z MBS s pismom z dne 11. junija 2007 (D(2007)16597).
It furthermore consulted experts in the field of in-vitro diagnostic medical devices on various occasions and, inter alia, in a meeting on 31 January 2008.
Ravno tako se je ob različnih priložnostih ter med drugim na sestanku z dne 31. januarja 2008 posvetovala s strokovnjaki s področja in vitro diagnostičnih pripomočkov.
Article 13 of Directive 98/79/EC (Particular health monitoring measure) has wider conditions than Article 8 (Safeguard clause) of this Directive.
Člen 13 Direktive 98/79/ES (Posebni ukrepi za spremljanje zdravstvenega stanja) vsebuje obsežnejše pogoje kot člen 8 (Zaščitna klavzula) te direktive.
Article 13 of Directive 98/79/EC does not require the same level of certainty of the acting authority with regard to the existence of a risk.
Člen 13 Direktive 98/79/ES ne zahteva iste ravni gotovosti pristojnega organa glede obstoja tveganja.
The analysis of the initial notification and of the later correspondence of Infarmed and the consultation of the parties concerned have shown that that it can be ascertained that the device under examination, when correctly maintained and used for its intended purpose, may compromise the health and/or the safety of patients, users or other persons, in the meaning of Article 8 of Directive 98/79/EC, as the essential requirement of being ‘state of the art’ is not met.
Na podlagi analize prvotne priglasitve in poznejše korespondence z INFARMED ter posvetovanja z zadevnimi strankami je mogoče potrditi, da lahko pripomoček, ki se pregleduje, ob ustreznem ravnanju in uporabi v predviden namen ogroža zdravje in/ali varnost bolnikov, uporabnikov ali drugih oseb v smislu člena 8 Direktive 98/79/ES, ker ne izpolnjuje bistvene zahteve, in sicer skladnosti z „najnovejšim tehničnim razvojem“.
As the test is slower and less reliable than other devices, it will detect less HIV infections than the other devices and may delay the start of an adequate anti-retroviral therapy.
Ker je test počasnejši in manj zanesljiv od drugih pripomočkov, se z njim odkrije manj okužb s HIV kot z drugimi pripomočki, kar lahko upočasni začetek ustrezne antiretrovirusne terapije.
The test could also contribute to an increased risk of missing HIV infected blood donors.
Test bi lahko povzročil tudi večje tveganje neodkritih krvodajalcev, okuženih s HIV.
It also compromises health in as much as its late and poor detection of the HIV infection may increase the risk of transmission to third persons, for instance by sexual intercourse.
Nenazadnje ogroža zdravje v smislu, da se lahko s poznim in slabim odkrivanjem okužbe s HIV poveča tveganje za prenos na tretje osebe, na primer s spolnimi odnosi.
According to the European Court of Justice [8] the view given by the European Commission in accordance with Article 8.2 of Directive 98/79/EC binds the Member State which has taken measures.
V skladu s stališčem Evropskega sodišča [8] mnenje Evropske komisije v skladu s členom 8(2) Direktive 98/79/ES obvezuje državo članico, ki je sprejela ukrepe.
Accordingly, this legal act is to be qualified as a decision,
Zato je treba ta pravni akt sprejeti kot odločbo –
The measures of the Portuguese authority Infarmed taken by letter of 29 July 2005 (DGREE/VPS/086/05 — Case No 9.5.1 — 329/2005) against the marketing of the in-vitro diagnostic medical device ‘HIV 1 & 2 Ab’ manufactured by the Italian company Medical Biological Service SRL are justified.
Ukrepi portugalskega organa INFARMED, sprejeti s pismom z dne 29. julija 2005 (DGREE/VPS/086/05 – št. primera 9.5.1.-329/2005), proti trženju in vitro diagnostičnega medicinskega pripomočka „HIV 1&2 Ab“, ki ga izdeluje italijansko podjetje Medical Biological Service S.R.L, so utemeljeni.
DGREE/VPS/086/05 — Case No 9.5.1 — 329/2005.
DGREE/VPS/086/05 – št. primera 9.5.1.-329/2005.
Test report No E-650/04 208600.
Poročilo o testu št. E-650/04 208600.
OJ L 131, 16.5.2002, p. 17.
UL L 131, 16.5.2002, str. 17.
Reference No A2.
Sklicna številka: A2.